Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

NCT03603548 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplant Rejection
Immunosuppression

Interventions

DRUG: Envarsus
DRUG: Advagraf

Sponsor

Medical University of Warsaw